Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosomes (GD-iExo-003) in Acute Ischemic Stroke
NCT06138210Phase 2Completed
- Sponsor
- Xuanwu Hospital
- Start
- Jun 2024
- Primary completion
- May 2026
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of GD-iExo-003 in ischemic stroke, sponsored by Xuanwu Hospital. Started Jun 2024; status: completed.
02
Drugs
GD-iExo-003
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06138210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06138210.